On June 13, Stifel reiterated a ‘Buy’ rating on the stock and a $72 price target. The bullish stance is in response to the ...

On June 30, analysts at Stifel reiterated a ‘Buy’ rating on the stock and a $186 price target. The bullish stance comes as ...

Barry Bannister, Stifel chief equity strategist, joins 'The Exchange' to discuss the markets, his bearish take on risks in ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $100.25, a high estimate of ...

Stifel Financial Corp. is facing allegations that it’s paying unreasonable administrative fees for its employee retirement ...

Stifel warns of a 12% decline in the S&P 500 index in the back half of 2025. Its strategist Barry Bannister explained why in ...

Paul Kilfoy has joined Bank of America Merrill Lynch as director, senior sales trader. The move sees Toronto-based Kilfoy ...

Vistagen Therapeutics, Inc. (NASDAQ:VTGN) is among the best growth stocks to invest in for the next 5 years. Analysts at ...

The pivotal trial for Neurogene's Rett syndrome gene therapy makes use of baseline controls and a rigorous endpoint that ...

Oracle Corp.'s stock was upgraded by analysts who see more opportunities for the company's large-scale cloud and artificial-intelligence infrastructure business - and that's just one reason why its ...

Bond issuance has ramped up by more than 35% year-on-year as declining birth rates push school districts to "keep up with the Joneses." ...

Cruise operators have fought hard against the plan, arguing they drop off passengers who patronize Mexican businesses.